Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial
- PMID: 27940512
- PMCID: PMC5192091
- DOI: 10.1542/peds.2016-1764
Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial
Abstract
Objective: Improving provider recommendations is critical to addressing low human papillomavirus (HPV) vaccination coverage. Thus, we sought to determine the effectiveness of training providers to improve their recommendations using either presumptive "announcements" or participatory "conversations."
Methods: In 2015, we conducted a parallel-group randomized clinical trial with 30 pediatric and family medicine clinics in central North Carolina. We randomized clinics to receive no training (control), announcement training, or conversation training. Announcements are brief statements that assume parents are ready to vaccinate, whereas conversations engage parents in open-ended discussions. A physician led the 1-hour, in-clinic training. The North Carolina Immunization Registry provided data on the primary trial outcome: 6-month coverage change in HPV vaccine initiation (≥1 dose) for adolescents aged 11 or 12 years.
Results: The immunization registry attributed 17 173 adolescents aged 11 or 12 to the 29 clinics still open at 6-months posttraining. Six-month increases in HPV vaccination coverage were larger for patients in clinics that received announcement training versus those in control clinics (5.4% difference, 95% confidence interval: 1.1%-9.7%). Stratified analyses showed increases for both girls (4.6% difference) and boys (6.2% difference). Patients in clinics receiving conversation training did not differ from those in control clinics with respect to changes in HPV vaccination coverage. Neither training was effective for changing coverage for other vaccination outcomes or for adolescents aged 13 through 17 (n = 37 796).
Conclusions: Training providers to use announcements resulted in a clinically meaningful increase in HPV vaccine initiation among young adolescents.
Trial registration: ClinicalTrials.gov NCT02377843.
Copyright © 2017 by the American Academy of Pediatrics.
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: Dr Brewer reports receiving commercial research grants from Merck, Pfizer, and GSK and serving on a paid advisory board for Merck. Dr Brewer did not use Merck resources to support this trial. The other authors declare no conflicts of interest.
Figures
Similar articles
-
Why is announcement training more effective than conversation training for introducing HPV vaccination? A theory-based investigation.Implement Sci. 2018 Apr 19;13(1):57. doi: 10.1186/s13012-018-0743-8. Implement Sci. 2018. PMID: 29673374 Free PMC article. Clinical Trial.
-
Organizational correlates of adolescent immunization: findings of a state-wide study of primary care clinics in North Carolina.Vaccine. 2013 Sep 13;31(40):4436-41. doi: 10.1016/j.vaccine.2013.06.092. Epub 2013 Jul 8. Vaccine. 2013. PMID: 23845803 Free PMC article.
-
Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.J Adolesc Health. 2016 Dec;59(6):710-715. doi: 10.1016/j.jadohealth.2016.07.021. Epub 2016 Sep 23. J Adolesc Health. 2016. PMID: 27671357
-
Adolescent human papillomavirus vaccination in the United States: Opportunities for integrating pharmacies into the immunization neighborhood.Hum Vaccin Immunother. 2017 Aug 3;13(8):1844-1855. doi: 10.1080/21645515.2017.1325980. Epub 2017 Jun 12. Hum Vaccin Immunother. 2017. PMID: 28605256 Free PMC article. Review.
-
Human papillomavirus vaccine introduction--the first five years.Vaccine. 2012 Nov 20;30 Suppl 5:F139-48. doi: 10.1016/j.vaccine.2012.05.039. Vaccine. 2012. PMID: 23199957 Review.
Cited by
-
Optimizing Cancer Prevention in Adolescents by Improving HPV Vaccine Delivery.N C Med J. 2023 Sep;85(1):33-36. doi: 10.18043/001c.91426. N C Med J. 2023. PMID: 39374359 Review.
-
Navigating the Evolving Landscape of COVID-19: Strategies to Increase Vaccine Confidence and Improve Vaccination Rates in the United States.Vaccines (Basel). 2024 Sep 19;12(9):1072. doi: 10.3390/vaccines12091072. Vaccines (Basel). 2024. PMID: 39340102 Free PMC article. Review.
-
Pediatric Oncology Providers' HPV Vaccine Knowledge, Attitude, Self-Efficacy, and Practice after Communication Training: A Comparison with a National Survey.Vaccines (Basel). 2024 Sep 17;12(9):1060. doi: 10.3390/vaccines12091060. Vaccines (Basel). 2024. PMID: 39340090 Free PMC article.
-
Vaccine hesitancy educational interventions for medical students: A systematic narrative review in western countries.Hum Vaccin Immunother. 2024 Dec 31;20(1):2397875. doi: 10.1080/21645515.2024.2397875. Epub 2024 Sep 25. Hum Vaccin Immunother. 2024. PMID: 39323010 Free PMC article.
-
Uptake of Human Papilloma Virus Vaccination and Associated Factors Among Female Students Attending Secondary Schools in South West Shoa, Oromia, Ethiopia, 2022.Cancer Control. 2024 Jan-Dec;31:10732748241285271. doi: 10.1177/10732748241285271. Cancer Control. 2024. PMID: 39288978 Free PMC article.
References
-
- Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP) . Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1–24 - PubMed
-
- Healthy People 2020. Immunization and infectious diseases. Available at: www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infe.... Accessed May 2, 2016
-
- National Cancer Institute Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer. A Report to the President of the United States from the President’s Cancer Panel. Bethesda, MD: National Cancer Institute; 2014
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
